Harmine

Overview

Harmine is a natural dual-specificity tyrosine phosphorylation-regulated kinase ( DYRK ) inhibitor with anticancer and anti-inflammatory activities. Harmine has a high affinity of 5-HT 2A serotonin receptor , with an K i of 397 nM.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Alzheimer's Disease | Products > Disease Areas > Parkinson's Disease | Products > Disease Areas > Obesity | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Cancer | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Neurological Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > DYRK | Products > Signaling Pathways > 5-HT Receptor

Product Information

• Catalog No.: HY-N0737A
• CAS No.: 442-51-3
• Molecular Formula: C13H12N2O
• Molecular Weight: 212.25
• Purity: 99.97%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 1 year , -20°C, 6 months
• Solubility: ≥ 2.5 mg/mL (11.78 mM); Clear solution
• Availability: In-stock

Source

Original product source